A detailed history of New York State Common Retirement Fund transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 149,908 shares of DNLI stock, worth $4.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
149,908
Previous 163,945 8.56%
Holding current value
$4.12 Million
Previous $3.81 Million 14.71%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$20.96 - $31.05 $294,215 - $435,848
-14,037 Reduced 8.56%
149,908 $4.37 Million
Q2 2024

Jul 31, 2024

BUY
$14.96 - $23.22 $571,023 - $886,307
38,170 Added 30.35%
163,945 $3.81 Million
Q1 2024

May 07, 2024

BUY
$15.83 - $23.35 $28,509 - $42,053
1,801 Added 1.45%
125,775 $2.58 Million
Q4 2023

Feb 01, 2024

SELL
$16.2 - $23.18 $95,239 - $136,275
-5,879 Reduced 4.53%
123,974 $2.66 Million
Q3 2023

Nov 07, 2023

BUY
$20.63 - $30.17 $81,571 - $119,292
3,954 Added 3.14%
129,853 $2.68 Million
Q2 2023

Aug 07, 2023

SELL
$23.37 - $32.96 $210,213 - $296,475
-8,995 Reduced 6.67%
125,899 $3.72 Million
Q1 2023

May 02, 2023

SELL
$21.91 - $32.67 $351,874 - $524,680
-16,060 Reduced 10.64%
134,894 $3.11 Million
Q4 2022

Jan 30, 2023

BUY
$26.28 - $33.92 $158,967 - $205,182
6,049 Added 4.17%
150,954 $4.2 Million
Q3 2022

Nov 08, 2022

BUY
$25.97 - $38.53 $105,853 - $157,048
4,076 Added 2.89%
144,905 $4.45 Million
Q2 2022

Aug 04, 2022

BUY
$20.88 - $35.19 $125,029 - $210,717
5,988 Added 4.44%
140,829 $4.15 Million
Q1 2022

May 05, 2022

BUY
$29.0 - $47.27 $1,566 - $2,552
54 Added 0.04%
134,841 $4.34 Million
Q4 2021

Feb 02, 2022

SELL
$42.59 - $55.02 $941,494 - $1.22 Million
-22,106 Reduced 14.09%
134,787 $6.01 Million
Q3 2021

Nov 02, 2021

SELL
$48.48 - $78.23 $1.13 Million - $1.83 Million
-23,368 Reduced 12.96%
156,893 $7.92 Million
Q2 2021

Aug 02, 2021

BUY
$50.3 - $78.44 $1.68 Million - $2.62 Million
33,358 Added 22.71%
180,261 $14.1 Million
Q1 2021

May 11, 2021

BUY
$53.8 - $81.53 $516,749 - $783,095
9,605 Added 7.0%
146,903 $8.39 Million
Q4 2020

Feb 08, 2021

BUY
$36.89 - $93.56 $2.15 Million - $5.45 Million
58,198 Added 73.58%
137,298 $11.5 Million
Q3 2020

Nov 05, 2020

BUY
$23.13 - $38.84 $497,295 - $835,060
21,500 Added 37.33%
79,100 $2.83 Million
Q2 2020

Aug 07, 2020

BUY
$16.01 - $28.82 $236,948 - $426,536
14,800 Added 34.58%
57,600 $1.39 Million
Q4 2019

Feb 05, 2020

SELL
$14.4 - $19.99 $97,920 - $135,932
-6,800 Reduced 13.71%
42,800 $746,000
Q2 2019

Aug 09, 2019

SELL
$18.5 - $28.14 $152,070 - $231,310
-8,220 Reduced 14.22%
49,600 $1.03 Million
Q1 2019

May 08, 2019

BUY
$17.99 - $24.65 $236,028 - $323,408
13,120 Added 29.35%
57,820 $1.34 Million
Q4 2018

Feb 08, 2019

BUY
$13.88 - $21.75 $331,732 - $519,825
23,900 Added 114.9%
44,700 $924,000
Q2 2018

Aug 10, 2018

BUY
$15.25 - $21.02 $183,000 - $252,240
12,000 Added 136.36%
20,800 $317,000
Q1 2018

May 10, 2018

BUY
$15.36 - $24.8 $135,168 - $218,240
8,800 New
8,800 $173,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.69B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.